A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the closely watched treatment.

It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1

Breast cancer is the second leading cause of cancer death in women. Early detection results in 99% five-year survival rates.

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday. The treatment, jointly developed with the Japanese company,

Questions about sex and intimacy often go unanswered for people with cancer. It's a glaring problem, especially for the growing number of young people being diagnosed.

The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — including colorectal, gastric, kidney and liver cancer — is also on the rise, though cancer among patients under 50 is still relatively rare overall, Dr. Partridge said.

Technology could soon do more than assist doctors. Thanks to advancements in cancer-identifying AI, it could actively save lives. A new study recently showcased how AI can revolutionize breast cancer detection, improving accuracy and easing radiologists’ workload.

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.

If you have breast cancer, you will have changes in your breast. These may be lumps or changes in the size or color of your breast, or changes in the appearance of your nipples. Breast cancer ...

During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic breast cancer who had progressed on multiple line of therapy.

"Boy Meets World" star Danielle Fishel said she is finished with radiation treatment for cancer and opened up about the side effects.

As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves patient outcomes.